Savolitinib in brain and leptomeningeal metastases from non-small cell lung cancer: a case report
In the population with non-small cell lung cancer (NSCLC), the incidence of mesenchymal–epithelial transition factor exon 14 (METex14) skipping mutations is approximately 3%–4%. However, the prevalence of this mutation appears to be lower among patients with NSCLC presenting with brain metastases (B...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-04-01
|
| Serie: | Frontiers in Oncology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1627170/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|